Why the study?
Despite widespread use of ELAAO in patients with AF, optimal procedural tactics and subsequent antithrombotic therapy remain poorly understood.
Does endovascular left atrial appendage occlusion improve safety and effectiveness in patients with atrial fibrillation?
Does endovascular left atrial appendage occlusion improve safety and effectiveness in patients with atrial fibrillation?
This review summarizes current evidence, clinical recommendations, and post-procedural antithrombotic strategies for endovascular left atrial appendage occlusion in atrial fibrillation.
Despite the increasingly widespread use of endovascular left atrial appendage occlusion (ELAAO) in the treatment of patients with atrial fibrillation (AF), the choice of optimal tactics for performing the procedure, especially subsequent antithrombotic therapy, remains poorly understood. This review was conducted with the aim of critically assessing current ideas about the safety and effectiveness of ELAAO in AF. The results of the most important clinical studies of ELAAO in patients with AF, the provisions of current clinical recommendations for this procedure are discussed. The available data on the possibilities of antithrombotic therapy after ELAAO and the prospects for future research in filling gaps in the evidence base for this technique are reviewed.
No takes yet. Share an insight, caveat, or question.
С. Г. Канорский (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: